Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1680254rdf:typepubmed:Citationlld:pubmed
pubmed-article:1680254lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:1680254lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:1680254lifeskim:mentionsumls-concept:C1167395lld:lifeskim
pubmed-article:1680254lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:1680254lifeskim:mentionsumls-concept:C0887937lld:lifeskim
pubmed-article:1680254lifeskim:mentionsumls-concept:C1517600lld:lifeskim
pubmed-article:1680254pubmed:issue3lld:pubmed
pubmed-article:1680254pubmed:dateCreated1991-10-18lld:pubmed
pubmed-article:1680254pubmed:abstractTextWe have previously demonstrated that depletion of Thy 1+ cells impairs the capacity of C57BL/6J, H-2b bone marrow cells, BMC, and BALB/cxC57BL/6J F1 BMC and spleen cells (SC) to establish mixed lymphoid chimerism and tolerance for donor-specific skin grafts in sublethally irradiated (240 cGy x3) BALB/c, H-2d hosts. In the present studies incubation with anti Ly2.2 + C markedly reduced the capacity of BALB/cxC57BL/6J, F1 SC to induce tolerance and chimerism (P less than .001). Incubation with anti-L3T4 + C had an inhibitory effect of borderline significance (P less than .04). Incubation with L-leucyl-L-leucine methyl ester (which removes NK cells, Tc, and precursor Tc) had no effect on the capacity of either C57BL/6J BMC or BALB/cxC57BL/6J F1 BMC or SC to establish chimerism and induce skin graft tolerance. These results suggest that tolerance-promoting Thy 1+ cells are not cytotoxic T cells. Both Ly2+ noncytotoxic CD8+ and L3T4+ noncytotoxic CD4+ cells may be involved. Alternatively the requisite Thy 1+ cells may be immature T cells that express both Ly2 and L3T4.lld:pubmed
pubmed-article:1680254pubmed:languageenglld:pubmed
pubmed-article:1680254pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1680254pubmed:citationSubsetIMlld:pubmed
pubmed-article:1680254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1680254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1680254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1680254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1680254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1680254pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1680254pubmed:statusMEDLINElld:pubmed
pubmed-article:1680254pubmed:monthSeplld:pubmed
pubmed-article:1680254pubmed:issn0041-1337lld:pubmed
pubmed-article:1680254pubmed:authorpubmed-author:PierceG EGElld:pubmed
pubmed-article:1680254pubmed:authorpubmed-author:SteersJ LJLlld:pubmed
pubmed-article:1680254pubmed:issnTypePrintlld:pubmed
pubmed-article:1680254pubmed:volume52lld:pubmed
pubmed-article:1680254pubmed:ownerNLMlld:pubmed
pubmed-article:1680254pubmed:authorsCompleteYlld:pubmed
pubmed-article:1680254pubmed:pagination526-30lld:pubmed
pubmed-article:1680254pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:meshHeadingpubmed-meshheading:1680254-...lld:pubmed
pubmed-article:1680254pubmed:year1991lld:pubmed
pubmed-article:1680254pubmed:articleTitleThy 1+ donor cells that promote allograft tolerance in sublethally irradiated MHC-disparate hosts.lld:pubmed
pubmed-article:1680254pubmed:affiliationUniversity of Kansas Medical Center, Kansas City 66103.lld:pubmed
pubmed-article:1680254pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1680254lld:pubmed